J Appl Biomed 10:63-70, 2012 | DOI: 10.2478/v10136-011-0023-2

Effect of shRNA mediated Smad4 gene silencing on the fibrosis of C2C12 myoblasts

Shiqiu Chen, Jiwu Chen^*, Shiyi Chen, Hongyun Li, Jia Jiang

Department of Sports Medicine, Huashan Hospital, Fudan University Shanghai Medical College, Shanghai, China

Our present study aimed to investigate the effect of lentiviral-mediated RNAi using short hairpin RNA (shRNA) targeting Smad4 on TGF-β1 induced fibrosis. shRNAs targeting Smad4 were designed and the most efficient shRNA was screened. This shRNA was introduced into a lentiviral vector which was used to infect C2C12 myoblasts, and then the Smad4 expression was detected. Cells were divided into: C2C12 cells group, TGF-β1 induction group, transfection group, and transfection after TGF-β1 induction group. C2C12 myoblasts were transfected with lentivirus carrying Smad4-shRNA and treated with TGF-β1 to induce the differentiation into myofibroblasts. Fluorescence Real-time-PCR and the western blot assay were employed to detect the expressions of collagen I and α-SMA. The results showed that the protein and mRNA expression of Smad4 in the C2C12 cells transfected with Smad4-shRNA1 was significantly reduced when compared with C2C12 before transfection. In the TGF-β1 induction group, the mRNA expressions of α-SMA and collagen I were significantly increased as compared to the C2C12 cells group. In the transfection after TGF-β1 induction group, the mRNA expressions of α-SMA and collagen I were significantly increased compared to the transfection group, and the protein expressions significantly increased, respectively. In the transfection after TGF-β1 induction group, the mRNA expressions of α-SMA and collagen I were significantly decreased compared to the TGF-β1 induction group, and the protein expressions significantly reduced, respectively. The results indicate that suppression of Smad4 expression can efficiently inhibit the TGF-β1 induced fibrosis in myoblasts. The findings suggest Smad4 may become a novel target for the treatment of skeletal muscle fibrosis.

Keywords: skeletal muscle injury; fibrosis; transforming growth factor-β1; C2C12 myoblast

Received: September 29, 2011; Revised: November 1, 2011; Published: July 31, 2012  Show citation